Article Impact Level: HIGH Data Quality: STRONG Summary of Nature Communications. https://doi.org/10.1038/s41467-026-70550-9 Dr. Neal I. Callaghan et al.
Points
- Scientists used a computational differential evolutionary approach to screen one hundred and sixty-nine different nutrient combinations to identify the optimal chemical environment for maturing stem cell-derived heart cells.
- The resulting C16 medium significantly improved the structural organization and metabolic energy production of the cells, making them function more like adult heart tissue rather than fetal-like models.
- When applied to three-dimensional miniature heart tissues, the new formulation produced more forceful beats and better electrical activity, enhancing the tissue’s predictive accuracy during pharmaceutical safety evaluations.
- This standardized culture medium helps address the common problem of unexpected cardiotoxicity in clinical trials by providing a more human-relevant biological model for early-stage laboratory drug screening.
- The research team has successfully licensed the technology for commercial use and founded a start-up to further apply machine learning toward optimizing high-performance media for regenerative heart medicine.
Summary
This study evaluated the efficacy of a novel, algorithm-optimized culture medium, designated C16, in promoting the physiological maturation of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Historically, hiPSC-CMs have remained functionally immature, exhibiting fetal-like metabolic and electrophysiological profiles that limit their predictive value in cardiotoxicity screening and disease modeling. The researchers utilized a differential evolutionary computational approach to screen 169 unique formulations over four iterative cycles, specifically targeting metabolic functionality and energy utilization as primary markers for adult-like tissue development.
The analysis demonstrated that hiPSC-CMs cultured in C16 medium achieved superior structural organization, enhanced calcium handling, and robust electrical activity compared to standard reference formulations. When applied to 3D microtissue formats, such as the Biowire II system, the optimized chemical cocktail facilitated a more forceful contractile profile and greater metabolic maturity. Multi-omic screening confirmed significant shifts in the transcriptomic and proteomic landscapes of the cells, indicating a more advanced developmental state. These improvements were sustained over a three-week culture period, even in the absence of exogenous electrical pacing, traditionally required for hiPSC-CM maturation.
The findings suggest that C16 medium provides a reliable, standardized workflow for generating highly functional cardiac tissue for pharmaceutical testing and regenerative medicine. By improving the reliability of in vitro models, this platform aims to reduce the incidence of late-stage clinical trial failures attributed to unanticipated cardiotoxicity, which currently complicates drug development. The successful commercialization of this formulation as MyoMax highlights its potential for broad integration into laboratory settings. Future research will focus on leveraging machine learning to further refine media components for specific therapeutic applications, such as the repair of infarcted myocardium.
Link to the article: https://www.nature.com/articles/s41467-026-70550-9
References
Callaghan, N. I., Durland, L. J., Chen, W., Kuzmanov, U., Miranda, M. Z., Ding, Y., Mirzaei, Z., Ireland, R. G., Reitz, C., Gorman, R. A., Wang, E. Y., Wagner, K., Kim, M. M., Audet, J., Santerre, J. P., Gramolini, A. O., Billia, F., Radisic, M., Mital, S., … Simmons, C. A. (2026). Advanced physiological maturation of human iPSC-derived cardiomyocytes using an algorithm-directed optimization of defined media components. Nature Communications. https://doi.org/10.1038/s41467-026-70550-9
